BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 962990)

  • 1. Association of medullary carcinoma of the thyroid with carcinoembryonic antigen.
    Ishikawa N; Hamada S
    Br J Cancer; 1976 Aug; 34(2):111-5. PubMed ID: 962990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of serum carcinoembryonic antigen in preoperative diagnosis of cancer in patients with thyroid nodules.
    Madeddu G; Langer M; Dettori G; Costanza C
    Cancer; 1980 May; 45(10):2607-10. PubMed ID: 7378994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carcinoembryonic antigen in thyroid disease.
    Economidou J; Karacoulis P; Manousos ON; Manesis E; Kydonakis A; Koutras DA
    J Clin Pathol; 1977 Sep; 30(9):878-80. PubMed ID: 915016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of circulating carcinoembryonic antigen and calcitonin in diagnosis of medullary thyroid carcinoma: a comparative study.
    Hamada S; Ishikawa N; Yoshi M; Morita R; Fukunaga M
    Endocrinol Jpn; 1976 Dec; 23(6):505-10. PubMed ID: 1022524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localization of carcinoembryonic antigen in medullary thyroid carcinoma by immunofluorescent techniques.
    Hamada S; Hamada S
    Br J Cancer; 1977 Nov; 36(5):572-6. PubMed ID: 337999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Demonstration of calcitonin and carcinoembryonic antigen (CEA) in medullary carcinoma of the thyroid (MCT) by immunoperoxidase technique.
    Talerman A; Lindeman J; Kievit-Tyson PA; Dröge-Droppert C
    Histopathology; 1979 Nov; 3(6):503-10. PubMed ID: 389771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physicochemical characteristics of carcinoembryonic antigen extracted from medullary carcinoma of the thyroid.
    Jullienne A; Calmettes C; Moukhtar MS; Milhaud G
    Oncodev Biol Med; 1980; 1(3):137-42. PubMed ID: 7279700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonparallel patterns of calcitonin and carcinoembryonic antigen levels in the follow-up of medullary thyroid carcinoma.
    Busnardo B; Girelli ME; Simioni N; Nacamulli D; Busetto E
    Cancer; 1984 Jan; 53(2):278-85. PubMed ID: 6690009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic and prognostic values of carcinoembryonic antigen in medullary carcinoma of the thyroid.
    Saad MF; Fritsche HA; Samaan NA
    J Clin Endocrinol Metab; 1984 May; 58(5):889-94. PubMed ID: 6707192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Family study of serum carcinoembryonic antigen in inherited medullary carcinoma of the thyroid.
    Kodama T; Fujino M; Endo Y; Obara T; Fujimoto Y; Adachi I; Abe K; Oda T; Wada T
    Cancer; 1979 Aug; 44(2):661-4. PubMed ID: 476574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcitonin and carcinoembryonic antigen in poorly differentiated follicular carcinoma.
    Calmettes C; Caillou B; Moukhtar MS; Milhaud G; Gerard-Marchant R
    Cancer; 1982 Jun; 49(11):2342-8. PubMed ID: 7042069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carcinoembryonic antigen and nonspecific cross-reacting antigen in thyroid cancer. An immunocytochemical study using polyclonal and monoclonal antibodies.
    Schröder S; Klöppel G
    Am J Surg Pathol; 1987 Feb; 11(2):100-8. PubMed ID: 2433953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the presence of autoantibodies in the plasma of patients suffering from medullary carcinoma of the thyroid.
    Calmettes C
    Biomed Pharmacother; 1985; 39(4):195-8. PubMed ID: 3904856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tumours markers. Calcitonin and carcinoembryonic antigen in medullary carcinoma of the thyroid (author's transl)].
    Calmettes C; Moukhtar MS; Milhaud G
    Presse Med (1893); 1979 Dec; 8(48):3947-50. PubMed ID: 530945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinoembryonic antigen and nonspecific cross-reacting antigen in medullary carcinoma of the thyroid.
    Kakudo K; Takami H; Katayama S; Matsuura N; Kamoshida S; Miyauchi A; Watanabe K
    Acta Pathol Jpn; 1990 Apr; 40(4):261-6. PubMed ID: 2371832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated CEA in breast cancer patients with overlooked medullary thyroid carcinoma.
    Andry G; Wildschutz T; Chantrain G; Bonnyns M; Dor P
    Eur J Surg Oncol; 1993 Jun; 19(3):305-8. PubMed ID: 8100201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioimmunoimaging of metastatic medullary carcinoma of the thyroid gland using an indium-111-labeled monoclonal antibody to CEA.
    Edington HD; Watson CG; Levine G; Tauxe WN; Yousem SA; Unger M; Kowal CD
    Surgery; 1988 Dec; 104(6):1004-10. PubMed ID: 3194829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case with poorly differentiated follicular carcinoma of the thyroid produced and secreted CEA].
    Kobayashi K; Yokozawa T; Ito Y; Matsuzuka H; Kuma K; Miyauchi A; Kakudo K
    Nihon Geka Gakkai Zasshi; 2003 Jun; 104(6):488-90. PubMed ID: 12854498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal carcinoembryonic antigen levels and medullary thyroid cancer progression: a multivariate analysis.
    Machens A; Ukkat J; Hauptmann S; Dralle H
    Arch Surg; 2007 Mar; 142(3):289-93; discussion 294. PubMed ID: 17372055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum tissue polypeptide antigen (TPA) in thyroid cancer.
    Martino E; Bambini G; Aghini-Lombardi F; Motz E; Pacini F; Lari R; Baschieri L; Pinchera A
    J Endocrinol Invest; 1984 Jun; 7(3):249-52. PubMed ID: 6547969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.